Loyens & Loeff supporting SHL Telemedicine with capital increase
Zurich/Tel Aviv - Loyens & Loeff Switzerland has advised SHL Telemedicine in relation to a successful capital increase and rights issuance on the SIX Swiss Exchange. The transaction is intended to allow patients in Israel, Germany and the USA to benefit from improved access to healthcare services.
(CONNECT) The law firm Loyens & Loeff Switzerland LLC consulted SHL Telemedicine, an Israeli supplier of digital healthcare solutions, in relation to a capital increase and rights issuance on the SIX Swiss Exchange. For this, Helvetische Bank AG acted as transaction manager. According to the information, the finalized transaction will offer patients in Israel, Germany and the USA improved and more efficient access to healthcare services.
The completed capital increase and rights issue generated gross proceeds of around 12.4 million Swiss francs. This capital increase will enable SHL to advance its strategic realignment and invest in operational systems in Germany, as well as supporting growth ambitions on the US market.
Existing shareholders received a subscription right to three new shares for each share they held. This resulted in the issuance of a total of 20,667,192 new ordinary shares, which more than doubled the number of outstanding shares.
“Our expertise in the cross-border capital market business and our integrated legal and tax approach helped SHL to complete a complex transaction securely and quickly. In this way, the company is in a position to accelerate its growth and make innovative digital healthcare services accessible to more patients and providers”, comments Daniel Dedeyan, partner at Loyens & Loeff Switzerland LLC. ce/nta












































